Aberdeen Israel Fund, Inc. Announces Performance Data And Portfolio
Composition
PHILADELPHIA, Jan. 7, 2013 /PRNewswire/ -- Aberdeen
Israel Fund, Inc. (the "Fund") (NYSE MKT: ISL), a closed-end
equity fund, announced today its performance data and portfolio
composition as of November 30,
2012.
(Logo: http://photos.prnewswire.com/prnh/20121106/NE07292LOGO
)
The Fund's total returns for various periods through
November 30, 2012 are provided
below. (All figures are based on distributions reinvested at
the dividend reinvestment price and are stated
net-of-fees):
|
Period
|
NAV
Total Return %
|
Market
Price Total Return %
|
|
Cumulative
|
Annualized
|
Cumulative
|
Annualized
|
|
Since
inception
(October
1992)
|
274.1
|
6.8
|
214.8
|
5.9
|
|
10-years
|
176.7
|
10.7
|
196.2
|
11.5
|
|
5-years
|
4.5
|
0.9
|
-16.0
|
-3.4
|
|
3-years
|
9.1
|
3.0
|
-0.2
|
-0.1
|
|
1-year
|
6.2
|
6.0
|
On November 30, 2012, the Fund's
net assets amounted to US$66.9
million and the Fund's NAV per share was $15.67.
As of November 30, 2012, the
portfolio was invested as follows:
|
Portfolio Composition
|
Percent
of
Net
Assets
|
|
Financials
|
23.0
|
|
Consumer, Non-Cyclical
|
19.2
|
|
Basic Materials
|
15.7
|
|
Technology
|
13.4
|
|
Health Care
|
9.7
|
|
Communications
|
6.8
|
|
Industrials
|
4.9
|
|
Other
|
3.1
|
|
Consumer, Cyclical
|
2.2
|
|
Cash
|
2.0
|
The Fund's ten largest equity holdings as of November 30, 2012, representing 65.9% of net
assets, were:
|
Stock
|
Percent
of
Net
Assets
|
|
Check
Point Software Technologies, Ltd.
|
9.8
|
|
Israel
Chemicals Limited
|
9.7
|
|
Teva
Pharmaceutical Industries, Ltd.
|
9.7
|
|
Perrigo
Company
|
8.3
|
|
United
Mizrahi Bank, Ltd.
|
6.8
|
|
Frutarom
Industries, Ltd.
|
5.0
|
|
OSEM
Investment, Ltd.
|
4.9
|
|
Bank Leumi
Le-Israel
|
4.0
|
|
Azrieli
Group
|
3.9
|
|
Bezeq
Israeli Telecomunication Corporation, Ltd.
|
3.8
|
Important Information
Aberdeen Asset Management Inc.
has prepared this report based on information sources believed to
be accurate and reliable. However, the figures are unaudited
and neither the Fund, Aberdeen Asset Managers Limited (effective
March 1, 2012, the Investment
Adviser), nor any other person guarantees their accuracy.
Investors should seek their own professional advice and should
consider the investment objectives, risks, charges and expenses
before acting on this information. Aberdeen is a U.S. registered
service mark of Aberdeen Asset Management PLC.
Closed-end funds are traded on the secondary market through one
of the stock exchanges. The Fund's investment return and principal
value will fluctuate so that an investor's shares may be worth more
or less than the original cost. Shares of closed-end funds may
trade above (a premium) or below (a discount) the net asset value
(NAV) of the fund's portfolio. There is no assurance that the Fund
will achieve its investment objective. Past performance does not
guarantee future results.
Total return figures with distributions reinvested at the
dividend reinvestment price are stated net-of-fees and represents
past performance. Past performance is not indicative of
future results, current performance may be higher or lower.
Holdings are subject to change and are provided for informational
purposes only and should not be deemed as a recommendation to buy
or sell the securities shown. Inception date October 29, 1992.
|
If you
wish to receive this information electronically, please contact:
InvestorRelations@aberdeen-asset.com
|
SOURCE Aberdeen Israel Fund, Inc.